Home » Topics » Regulatory » Patents

Patents
RSS

Celgene presents new cereblon-binding PROTACs

Jan. 17, 2022

New GLP-1 receptor agonists identified at Guangzhou Henovcom Bioscience

Jan. 17, 2022

BeiGene discloses non-receptor tyrosine-protein kinase TYK2 inhibitors

Jan. 17, 2022

BioWorld MedTech Patent Highlights: Week 1

From Current Patent Gazette

Jan. 14, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Sage Therapeutics discloses new GABA-A receptor modulators

Jan. 14, 2022

Gilead Sciences synthesizes new HIV antivirals

Jan. 14, 2022

X4 Pharmaceuticals presents new CXCR4 antagonists

Jan. 14, 2022

Medshine Discovery divulges new GTPase KRAS G12C mutant inhibitors

Jan. 14, 2022

Icahn School of Medicine at Mount Sinai patents DYRK1A inhibitors

Jan. 14, 2022

Alchemedicine discovers CK1 and/or TGFBR1 inhibitors

Jan. 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy
BioWorld
Eli Lilly and Co. plans to buy Centessa Pharmaceuticals plc for $6.3 billion in up-front cash and another potential $1.5 billion through contingent value rights,...